This document summarizes strategies for adopting new chronic patient services at the Hospital Clinic of Barcelona. It discusses:
1. Implementing patient summary records and electronic prescriptions to improve interoperability among providers in Barcelona and across Spain/Europe.
2. Deploying an integrated care model at Barcelona Esquerra involving hospitals, primary care, social services, and mental health to better coordinate care for chronic respiratory patients through structures like an integrated health sector and chronic care unit.
3. Developing integrated care strategies for chronic patients using enhanced lifestyle programs, standardized care paths, and remote monitoring to modulate disease progression and efficiently manage patients in a network of community providers.
Graeme Osborne
Director, National Health IT Board
Peter Gow
Chair, National Information Clinical Leadership Group
Ernie Newman
Chair, NHITB Consumer Panel
Barry Vryenhoek
Chief Executive, healthAlliance New Zealand Ltd
(Thursday, 9.45, Keynote)
This MOH presentation proposes the wholesale reform and privatisation of the Malaysian healthcare system, instead of reforming and strengthening the present system.
Graeme Osborne
Director, National Health IT Board
Peter Gow
Chair, National Information Clinical Leadership Group
Ernie Newman
Chair, NHITB Consumer Panel
Barry Vryenhoek
Chief Executive, healthAlliance New Zealand Ltd
(Thursday, 9.45, Keynote)
This MOH presentation proposes the wholesale reform and privatisation of the Malaysian healthcare system, instead of reforming and strengthening the present system.
Los cuadros de mando: herramientas de control del cumplimiento de la estrateg...ANTARES CONSULTING
Presentación realizada por Juan Carlos Álvarez, en la jornada: "Las fundaciones que realizan acción social: de la donación a la inversión social" (15/03/2012)
The impact of eHealth on Healthcare Professionals and Organisations: e-health and Healthcare Organization. Piqué J. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
Los cuadros de mando: herramientas de control del cumplimiento de la estrateg...ANTARES CONSULTING
Presentación realizada por Juan Carlos Álvarez, en la jornada: "Las fundaciones que realizan acción social: de la donación a la inversión social" (15/03/2012)
The impact of eHealth on Healthcare Professionals and Organisations: e-health and Healthcare Organization. Piqué J. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
Business Experience in Implementing an Advanced Telemonitoring Service. Valdivieso Martinez B. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
Katrina Percy: Working with partners to deliver high quality health and socia...The King's Fund
Katrina Percy, Chief Executive of Southern Health NHS Foundation Trust, talks about the health system in Hampshire and the key elements of Southern Health’s integrated care strategy.
Brief view of the achievements of a regional long-term e-health strategy done in Andalusia, the southernmost region of Spain. It is a comprehensive strategy for the whole population of this spanish region: more than 8 million inhabitants. EHR, electronic prescription, appointment, lab tests, image and others. An independent economic study shows a 260 euros of benefit for each 100 euros invested after 10 years of starting the initiative
Eduard Portella. Nuestro sistema sanitario "después" de la crisis. Una aproxi...ANTARES CONSULTING
Presentación de Eduard Portella, presidente de Antares Consulting para la jornada "Gestión sanitaria en tiempos de crisis", celebrada en Madrid el 25 de marzo de 2015
Presentación realizada por Yolanda Rueda, en la jornada: "Las fundaciones que realizan acción social: de la conación a la inversión social" (15/03/2012)
Jornada sobre Gestión Sanitaria en la crisis económicaANTARES CONSULTING
Programa de la Jornada sobre Gestión Sanitaria en la crisis económica organizada por la Agència Valenciana de Salut y el Hospital San Joan, que tendrá lugar en el Auditorio del Palacio de Congresos y Colegio de Médicos de Alicante el próximo 26 de mayo de 2011.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Josep Roca. Gestión hospitalaria en tiempos de crisis
1. Estrategias para la adopción de nuevas
prestaciones de servicios para pacientes
crónicos
La experiencia del Hospital Clínico de Barcelona
Josep Roca
Hospital Clinic.IDIBAPS.University of Barcelona
3. INTEROPERABILITY AMONG PROVIDERS
• Level A - Barcelona – Esquerra
• Level B - Spain and Europe
Patient summary record and electronic prescription
BARCELONA ESQUERRA • 540.000 habitantes
EAPs ICS
EAPsCAPSE • 18 ABS y 2 CAPs II (5 empresas
EAP Gesclínic distintas)
EAP LesHortes 5D
EAPsVallplasa
HospitalClínic
• 4 Hospitales
5E
HospitalSagratCor 4C
Clínica Plató
4B
5C 5B • 1 Centro Sociosanitario principal y
5A
4A
CAP II Manso (ICS)
3E 3G 2C 2E otros de menor dimensión
CAP IINumància(ICS) 2B 2D
3D
2A
3B • 3 Proveedores de Salud Mental
3A
3C
• Servicio de Emergencias Médicas de
Cataluña
4. Deployment at Barcelona Esquerra 2009:
Territorial Health Care Comission
Barcelona Esquerra
Institutions Permanent Comission
representative
Technical
Implementation Management
Redesign & follow-up Team
Process 1 Specialized Care
Mental health
Pediatric care
Health Transport
Pharmacy
Home Care
Emergencies
Process 2
Social Care
IT
Process 3
Process 4
Operational Committees
5. Deployment at Barcelona Esquerra 2009:
Hospitals vs territorial healthcare
Community
HOSPITAL Care
Family
Process Units
Transplant Physician
Nurse
Dementia
Social
COPD
Territorial Worker
Healthcare
Home
CHF Care
7. STRUCTURES RELEVANT TO CONTINUITY OF CARE
IN CHRONIC RESPIRATORY PATIENTS
INTEGRATED HEALTH SECTOR BARCELONA-ESQUERRA (AISBE)
CHRONIC CARE UNIT
LINKCARE HEALTH SERVICES S.L.
CLINICAL INSTITUTES
8. Integrated Care Strategies for
Chronic Patients
- enhanced citizens life style
- well standardized care paths
Modulation of disease progress
Efficient patient management
9. Service model
• Target patients
• Management by programs
• Well standardized interventions
• Patient-centered care
providers network
Support
Patient
center
Personal Health Folder
• Triage
• Self-management
• Remote monitoring
13. Current Deployment at
Barcelona Esquerra (Nexes)
Wellness & Rehabilitation
Frailty - Transitional care - Palliative care
Home hospitalisation
Support
14. Need for operational definitions of frailty
and identification of associated services
System-related factors Patient-related factors Scenario
Organizational model Socio-demographic Integrated care strategies
with ICT support
Professional & health care Chronic conditions
resources
Treatment & self management
Health & Social resources
Dependency
Quality of life
Satisfaction & self-efficacy
information
15. Assignment level of complexity (frailty)
VERY LOW LOW COMPLEXITY HIGH COMPLEXITY
COMPLEXITY in addition, they show some of the
following factors
Patients with 1. More than two co-morbid conditions and Charlson 1. High hospitalization rate in the
none of these index > 2 previous year (> 2 admissions
factors 2. High score of anxiety/depression (HAD > 6) including emergency room visits)
3. Home bound being alone at home for more than 2. Tertiary level therapy at home (non-
50% of the day invasive mechanical ventilation,
4. Home bound with a caregiver of similar age etc…)
5. Treatment adherence assessed by Morinsky- 3. End-stage complex disease
Greens (> 4 different pills/day)
6. Oxygen therapy
7. Need of social support
8. Need of low complexity home care services
(wound cures)
16. Emergency room Hospital specialized units Day care / Home hospitalization
Eligibility assessment of all patients (+ 40 years old) admitted because of
exacerbation of COPD + other respiratory diseases
Not eligible (EXCLUSION CRITERIA)
Accepted to participate
Inability to use the ICT Eligible (INCLUSION CRITERIA)
Living in the area
equipment (patient and
Informed consent
caregiver)
Yes No
Advanced cancer
Patient assessment .
Assignment level of complexity (frailty group)
Number of participants who do
Very low Low High not accept to participate and
their reasons are recorded
Baseline measurements
Randomization
CURRENT CARE
Training/Installation
INTERVENTION CURRENT CARE AT THE
PARTICIPATING HOSPITAL
Very low
Low
High
Follow-up measurements
17. Tailored intervention by level of complexity (frailty)
COMPLEXIT
VERY LOW
LOW COMPLEXITY
HIGH COMPLEXITY
1. Education of self-management including co-morbidities
(pharmacological/non-pharmacological therapies) and
elaboration of personalized action plan
2. Access to the call centre
3. Access to personal health folder
4. Visit at home within 72 h including primary care team and social
support team
5. Video-conference during 1 week
6. Remote sensors monitoring (defined on individual basis by the
specialists)
7. Remote questionnaire monitoring
8. Home-based rehabilitation (physiotherapists and/or occupational
therapists)
9. Connection with convalescence centre (if needed)
10. Video-conference up to 1 month (defined on individual basis by the
specialists)
11. Additional remote sensors (defined on individual basis by the
specialists)
12. Remote support of the specialists including home or day hospital visit
when needed
18. ROADMAP
We should develop the potential to be at the forefront of healthcare delivery innovation
by embracing the evolution of medicine and technology
The 4 P’s of Medicine: System
Predictive Medicine
Personalized
Preventive
Participatory 2020
Personal Health
Services
Evolved Integrated
Care Services 2011
Use of technology